Ads
related to: emcure pharmaceuticals locations
Search results
Results From The WOW.Com Content Network
Emcure Pharmaceuticals was established in 1981 by Satish Mehta, who began the company with a bank loan of ₹ 3 lakh (about US$35,000 then) after graduating from IIM-A. [9] In the 1990s, the company transitioned from being a contract manufacturing organization to a producer of generic drugs .
Location of India. India is a country in ... Emcure Pharmaceuticals: Health care Pharmaceuticals Pune: 1983 Pharma P A Engineers India: Industrials Engineering and ...
Daund is currently being developed as a hub for pharmaceutical industries, and currently has facilities of companies such as Cipla, Emcure Pharmaceuticals, and Dia Ichi. Transportation [ edit ]
Indian generic drugmaker Emcure Pharmaceuticals and U.S. vaccine developer HDT Bio have settled allegations that Emcure stole HDT trade secrets during their joint work on a COVID-19 shot, the ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. [1] She is the Executive director of Emcure Pharmaceuticals. [2] She has also been a prominent investor in Shark Tank India investing in over 100 companies.
The company's first international move took it to Russia in 1992. There, Dr. Reddy's formed a joint venture with the country's biggest pharmaceuticals producer, Biomed.They pulled out in 1995 amid accusations of scandal, involving "a significant material loss due to the activities of Moscow's branch of Reddy's Labs with the help of Biomed's chief executive". [8]
On Thursday, Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) stock plunged after the company revealed disappointing data from the Phase 3 TrustTSC trial of oral ganaxolone for seizures associated with ...